SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-10-032268
Filing Date
2010-02-16
Accepted
2010-02-16 15:59:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 dsc13ga.htm SC 13G/A 59275
  Complete submission text file 0001193125-10-032268.txt   61316
Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02140
Business Address 100 HAYDEN AVENUE LEXINGTON MA 02140 6174972070
AMAG PHARMACEUTICALS INC. (Subject) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-38286 | Film No.: 10607521
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O BROOKSIDE CAPITAL, LLC 111 HUNTINGTON AVENUE BOSTON MA 02199
Business Address C/O BROOKSIDE CAPITAL, LLC 111 HUNTINGTON AVENUE BOSTON MA 02199 617-516-2000
Brookside Capital Trading Fund, L.P. (Filed by) CIK: 0001461875 (see all company filings)

IRS No.: 264233731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A